Arcturus Therapeutics Newsroom

Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT) and Madrigal Pharmaceuticals (MDGL)

TipRanksDec 18 13:54

H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63

Futu NewsDec 17 19:31

Arcturus Therapeutics Price Target Maintained With a $63.00/Share by HC Wainwright & Co.

Dow JonesDec 17 19:27

Arcturus Therapeutics Analyst Ratings

BenzingaDec 16 21:17

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $74

Futu NewsDec 6 20:31

H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63

Futu NewsNov 8 20:35

Arcturus Therapeutics: Strong Buy Rating Backed by Promising Kostaive Sales and Promising Pipeline Developments

TipRanksNov 8 20:25

Positive Outlook for Arcturus Therapeutics' Vaccine Production and Distribution Spurs Buy Rating

TipRanksOct 4 14:42

H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63

Futu NewsOct 2 00:32

Arcturus Therapeutics Price Target Maintained With a $63.00/Share by HC Wainwright & Co.

Dow JonesOct 2 00:22

Wells Fargo Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $58

Futu NewsOct 1 17:31

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $72

Futu NewsSep 20 19:31

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $72

Futu NewsSep 17 19:34

Leerink Partners Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating

Futu NewsSep 13 14:32

Arcturus Therapeutics Analyst Ratings

BenzingaSep 10 00:54

William Blair Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating

Futu NewsSep 5 00:32

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $72

Futu NewsSep 4 19:31

Buy Rating Affirmed: Arcturus Therapeutics' Promising Cystic Fibrosis Program Progress

TipRanksSep 4 19:11

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $72

Futu NewsAug 27 19:33

Arcturus Therapeutics Analyst Ratings

BenzingaAug 12 18:52